Breaking news from “The Pink Sheet” DAILY
Executive Summary
Visit 1www.ThePinkSheetDAILY.com for coverage of the latest developments in the pharmaceutical industry, including the approval of Bristol-Myers Squibb/Otsuka's antipsychotic Abilify for use in acute bipolar mania, J&J's subpoena from the HHS Inspector General requesting documents relating to its sales and marketing of Procrit and Gov. Schwarzenegger's vetoes of California importation legislation. To sign up for a free trial of "The Pink Sheet" DAILY, visit our website or call customer service at 800-332-2181...